PAMYX
Price
$13.69
Change
+$0.03 (+0.22%)
Updated
Sep 11 closing price
Net Assets
2.4B
TFEBX
Price
$12.07
Change
+$0.02 (+0.17%)
Updated
Sep 11 closing price
Net Assets
24.17B
Interact to see
Advertisement

PAMYX vs TFEBX

PAMYX vs TFEBX Comparison Chart in %
View a ticker or compare two or three
VS
PAMYX vs. TFEBX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMYX is a Hold and TFEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TFEBX has more cash in the bank: 24.2B vs. PAMYX (2.4B). PAMYX pays higher dividends than TFEBX: PAMYX (3.81) vs TFEBX (3.37). PAMYX was incepted earlier than TFEBX: PAMYX (19 years) vs TFEBX (10 years). PAMYX (0.65) is less costly to investors than TFEBX (0.27). TFEBX is a more actively managed with annual turnover of: 56.00 vs. PAMYX (41.00). PAMYX has a lower initial minimum investment than TFEBX: PAMYX (0) vs TFEBX (1000000). PAMYX annual gain was more profitable for investors over the last year : 0.80 vs. TFEBX (-2.66). PAMYX return over 5 years is better than : -6.45 vs. TFEBX (-11.08).
PAMYXTFEBXPAMYX / TFEBX
Total Expense Ratio0.650.27241%
Annual Report Gross Expense Ratio0.650.27241%
Fund Existence19 years10 years-
Gain YTD-1.011-3.28531%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.4B24.2B10%
Annual Yield % from dividends3.813.37113%
Returns for 1 year0.80-2.66-30%
Returns for 3 years5.051.42355%
Returns for 5 years-6.45-11.0858%
Returns for 10 years-6.14N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGTHX87.770.48
+0.55%
American Funds Growth Fd of Amer A
TPVIX20.39N/A
N/A
Timothy Plan Small Cap Value I
TRERX17.94N/A
N/A
Nuveen International Eq Retire
TLISX15.50N/A
N/A
Nuveen Quant Intl Small Cap Eq A
AIFFX17.16N/A
N/A
Aristotle International Equity I-2